… the first three months after discontinuation of inhaled corticosteroids was higher than the rate
… of low-dose inhaled corticosteroids is associated with a decreased risk of death from asthma…

… Finally, the trial should have sufficiently long follow-up to also measure the anticipated benefit
from ICS discontinuation in terms of risk reduction, particularly on pneumonia. Indeed, the …

… The therapeutic value of inhaled corticosteroids (ICSs) for COPD is limited. … risk when
bronchodilator treatment is optimized. Here we report on the feasibility and risks of ICS withdrawal …

… or even less likely to result in study discontinuation because of an AE than a moderate-dose …
the risk of an AE leading to study discontinuation (risk ratio, 0.56; 95% CI, 0.14-2.43; vs risk …

Purpose In the Withdrawal of Inhaled Steroids during Optimized Bronchodilator Management
(WISDOM) trial, inhaled corticosteroid (ICS) withdrawal in patients with chronic obstructive …

… Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease: the COPE study. Am J Respir Crit Care Med 2002;166:1358-63 …

… of withdrawal of inhaled corticosteroids in COPD wherein it was reported that withdrawal of
ICS did … relevant risk of severe exacerbation was still present (RR >1.2). Citation38 Moreover, …

… Inhaled corticosteroids (ICSs) are widely used in chronic obstructive pulmonary disease (COPD). …
Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive …

… fracture risk after cessation of inhaled corticosteroids, each user who stopped therapy before
the end of study was followed from 91 days after the last inhaled corticosteroid prescription …

… 24% fewer rehospitalizations and a 29% risk reduction for mortality during a 1-year follow-up…
demonstrated that discontinuation of ICS was associated with a 37% reduction in the risk of …